{"id":"W4391693695","doi":"10.1136/bmjgast-2023-001218","title":"Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trial","year":2024,"lang":"en","type":"article","venue":"BMJ Open Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"Barrie Urology Group; University of Calgary; Western University","funders":"Allergan; Genentech; European Crohn's and Colitis Organisation; Celltrion; Wellcome Trust; Celgene; Janssen Pharmaceuticals; Gilead Sciences; Sanofi; Takeda Pharmaceuticals U.S.A.; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; Mylan; GlaxoSmithKline","keywords":"Medicine; Ulcerative colitis; Interim analysis; Internal medicine; Randomized controlled trial; Intention-to-treat analysis; Verdict; Vedolizumab; Endoscopy; Observational study; Surgery; Gastroenterology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006475046,0.0001874276,0.0003503126,0.00005620027,0.0001193667,0.000147592,0.0002162817,0.00005279846,0.00002570175],"category_scores_gemma":[0.0000948401,0.00009598527,0.0001455798,0.00004607655,0.0001313432,0.00001372113,0.0001103482,0.00005144283,8.064603e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004202039,"about_ca_system_score_gemma":0.0001641121,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003206978,"about_ca_topic_score_gemma":0.0001940392,"domain_scores_codex":[0.9985024,0.0004969477,0.0003509004,0.0003408168,0.0000859954,0.0002229044],"domain_scores_gemma":[0.9993429,0.000166421,0.0001297603,0.000226534,0.00008936511,0.00004501768],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9427865,0.0001647226,0.0523561,0.00001044511,0.001961684,0.00001401804,0.0001304187,0.002142323,0.00002527599,0.00001859434,0.0002127385,0.0001771905],"study_design_scores_gemma":[0.6723201,0.008327006,0.3053266,0.000019555,0.0007003702,0.000002984981,0.00005900016,0.01250645,0.0000771559,0.00001601241,0.000516388,0.0001284353],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7423466,0.000003281141,0.01645038,0.0002079683,0.00005282872,0.240815,0.00006186683,0.000005527274,0.00005656434],"genre_scores_gemma":[0.677327,5.096999e-7,0.0007503279,0.0002159678,0.00006965921,0.3213593,0.0001045117,0.00001464219,0.0001581336],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2704664,"threshold_uncertainty_score":0.3914165,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0243157338020686,"score_gpt":0.3257400812305416,"score_spread":0.301424347428473,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}